AstraZeneca plc (AZN) stock is lower by -5.85% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives AZN stock a score of 59 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 62. AZN's rank also includes a long-term technical score of 57.
AZN has an Overall Score of 59. Find out what this means to you and get the rest of the rankings on AZN!
AstraZeneca plc (AZN) stock has gained 2.61% while the S&P 500 is higher by 2.82% as of 11:08 AM on Tuesday, Oct 4. AZN is higher by $1.45 from the previous closing price of $55.55 on volume of 2,084,346 shares. Over the past year the S&P 500 has fallen -12.05% while AZN is lower by -5.85%. AZN earned -$0.43 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 65.02.
Click Here to get the full Stock Report for AstraZeneca plc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
